You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Heart Failure and Biomarkers: Practical Strategies and Protocols

  • Authors: Javed Butler, MD, MPH, MBA; Carolyn Su Ping Lam, MBBS, PhD, MRCP; A. Mark Richards, MD, PhD; Adriaan A. Voors, MD, PhD
  • CME / ABIM MOC / CE Released: 11/10/2017
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 11/10/2019, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for cardiologists, emergency medicine physicians, primary care physicians, nurses, and other healthcare providers involved in the management of patients with heart failure (HF).

The goal of this activity is to enhance the adoption of natriuretic peptide measurements into HF management.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest clinical guideline recommendations on the use of biomarkers in patients with heart failure (HF)
  • Have greater competence related to
    • Clinical interpretation of biomarker results in HF
    • Practical strategies to use N-terminal pro B-type natriuretic peptide (NT-proBNP) to guide therapy for patients with HF, both during and outside of hospitalization


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Javed Butler, MD

    Professor of Medicine; Professor of Physiology and Biophysics; Director, Division of Cardiology; Co-Director, Heart Institute, Stony Brook University, Stony Brook, New York

    Disclosures

    Disclosure: Javed Butler, MD, MPH, MBA, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Amgen Inc.; AstraZeneca Pharmaceuticals, LP; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; CardioCell, LLC; Janssen Pharmaceuticals; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Relypsa, Inc.; ZS Pharma
    Served as a speaker or a member of a speakers bureau for: Novartis Pharmaceuticals Corporation

    Dr Butler does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Butler does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Panelists

  • Carolyn Su Ping Lam, MBBS, PhD, MRCP

    Professor and Senior Consultant, Duke- National University of Singapore Graduate Medical School; Senior Consultant, National Heart Centre; Chairperson, Asia Pacific Association of Women's Cardiovascular Disease, Singapore

    Disclosures

    Disclosure: Carolyn Su Ping Lam, MBBS, PhD, MRCP, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Abbott Laboratories; Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Corvia Medical, Inc.; Janssen Research & Development, LLC; Merck & Co., Inc.; Menarini Group; Novartis Pharmaceuticals Corporation; Roche; Stealth BioTherapeutics Inc.; Takeda Pharmaceuticals North America, Inc.
    Received grants for clinical research from: Bayer HealthCare; Boston Scientific; Medtronic, Inc.; Thermo Fisher Scientific Inc.; Vifor Pharma

    Dr Lam does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Lam does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • A. Mark Richards, MD, PhD

    Professor, Department of Medicine, University of Otago; Director, Christchurch Heart Institute, Christchurch, New Zealand; Professor, Department of Medicine; Director, Cardiovascular Research Institute, National University of Singapore, Singapore

    Disclosures

    Disclosure: A. Mark Richards, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Novartis Pharmaceuticals Corporation; Roche
    Served as a speaker or a member of a speakers bureau for: Novartis Pharmaceuticals Corporation; Roche
    Received grants for clinical research from: Abbott Laboratories; Roche; Thermo Fisher Scientific Inc.

    Dr Richards does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Richards does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

  • Adriaan A. Voors, MD, PhD

    Professor of Cardiology, University Medical Center, Groningen, Netherlands

    Disclosures

    Disclosure: Adriaan A. Voors, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alere; Amgen Inc.; Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Cardio3 Biosciences; Celadon Laboratories; GlaxoSmithKline; Merck Sharp & Dohme GmbH.; Novartis Pharmaceuticals Corporation; SERVIER; Singulex; sphingotec GmbH; Stealth BioTherapeutics Inc.; Trevena, Inc.; Vifor Pharma; ZS Pharma, Inc.

    Dr Voors does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

    Dr Voors does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Editor(s)

  • Joy P. Marko, MS, APN-C, CCMEP

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Joy P. Marko, MS, APN-C, CCMEP, has disclosed no relevant financial relationships

  • Kalanethee Paul-Pletzer, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Kalanethee Paul-Pletzer, PhD, has disclosed no relevant financial relationships

CME Reviewer / Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.


Accreditation Statements


Interprofessional Continuing Education


In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Heart Failure and Biomarkers: Practical Strategies and Protocols

Authors: Javed Butler, MD, MPH, MBA; Carolyn Su Ping Lam, MBBS, PhD, MRCP; A. Mark Richards, MD, PhD; Adriaan A. Voors, MD, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 11/10/2017

Valid for credit through: 11/10/2019, 11:59 PM EST

processing....

  • Print